Predictive Value for Galectin 3 and Cardiotrophin 1 in Hemodialysis Patients

Cardiotrophin-1 is associated with increased risk of arterial stiffness

(2015) Hao-Chang Hung et al.   Biomarkers in Medicine

Galectin-3 and heart failure: Prognosis, prediction & clinical utility

(2015) Mando D. Filipe et al.   CLINICA CHIMICA ACTA

Galectin-3 and post-myocardial infarction cardiac remodeling

(2015) Wouter C. Meijers et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Plasma Cardiotrophin-1 as a Marker of Hypertension and Diabetes-Induced Target Organ Damage and Cardiovascular Risk

(2015) Luis Gamella-Pozuelo et al.   MEDICINE

Superior Predictive Value for NTproBNP Compared with High Sensitivity cTnT in Dialysis Patients: A Pilot Prospective Observational Study

(2015) Luminita Voroneanu et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Prognostic Value of Cardiac Troponin in Patients With Chronic Kidney Disease Without Suspected Acute Coronary Syndrome

(2014) Erin D. Michos et al.   ANNALS OF INTERNAL MEDICINE

Galectin-3: an emerging all-out player in metabolic disorders and their complications

(2014) G. Pugliese et al.   GLYCOBIOLOGY

Plasma Cardiotrophin-1 Levels are Associated With Hypertensive Heart Disease: A Meta-Analysis

(2014) Kangxing Song et al.   Journal of Clinical Hypertension

Aldosterone Induced Galectin-3 Secretion In Vitro and In Vivo: From Cells to Humans

(2014) Yen-Hung Lin et al.   PLoS One

Galectin‐3, a Biomarker Linking Oxidative Stress and Inflammation With the Clinical Outcomes of Patients With Atherothrombosis

(2014) Julio Madrigal‐Matute et al.   Journal of the American Heart Association

Macrophages promote renal fibrosis through direct and indirect mechanisms

(2014) David J. Nikolic-Paterson et al.   Kidney International Supplements

2013 ACCF/AHA Guideline for the Management of Heart Failure

(2013) Clyde W. Yancy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Elevated Galectin-3 Precedes the Development of CKD

(2013) C. M. O'Seaghdha et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis

(2012) Laurent Calvier et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis

(2012) Lili Yu et al.   Circulation-Heart Failure

Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure

(2012) Dirk J. Lok et al.   Clinical Research in Cardiology

Cardiotrophin 1 Is Involved in Cardiac, Vascular, and Renal Fibrosis and Dysfunction

(2012) Natalia López-Andrés et al.   HYPERTENSION

Usefulness of Plasma Galectin-3 Levels in Systolic Heart Failure to Predict Renal Insufficiency and Survival

(2011) W.H. Wilson Tang et al.   AMERICAN JOURNAL OF CARDIOLOGY

A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone

(2011) Natalia López-Andrés et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link?

(2011) Kitty J. Jager et al.   Kidney International Supplements

Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis

(2009) Dinanda J. de Jager   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients

(2009) R. Paniagua et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION